PMC4151539_01
The figure shows the dramatic response of metastatic urethral cancer to nanoparticle albumin-bound (nab) paclitaxel. CT scan performed before therapy (a) showed an 11.5 cm metastatic mass in the left pelvis. This mass decreased to 3.5 cm after 5 months of nab-paclitaxel (b).
CRIU2014-489686.001.jpg
PMC4151539_01_CRIU2014-489686.001.jpg
fig1
Dramatic improvement was noted after 5 months of therapy with 70% reduction in the size of the pelvic masses on CT scan (Figure 1).